𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pathophysiology of Parkinson's disease: From clinical neurology to basic neuroscience and back

✍ Scribed by Hagai Bergman; Günther Deuschl


Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
255 KB
Volume
17
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

✦ Synopsis


Parkinson's disease (PD) is characterized by motor and nonmotor (cognitive and limbic) deficits. The motor signs of PD include hypokinetic signs such as akinesia/bradykinesia, rigidity and loss of normal postural reflexes, and hyperkinetic signs such as tremor. Dopamine depletion in the striatum is the hallmark of PD and of its animal models, still the pathophysiology of the parkinsonian symptoms and especially of parkinsonian tremor are under debate. The most extreme hypotheses argue about peripheral versus central nervous system origin, intrinsic cellular oscillator versus network oscillators, and basal ganglia-based pathophysiology versus cerebellar-thalamic based pathophysiology. Recent studies support the view that parkinsonian symptoms are most likely due to abnormal synchronous oscillating neuronal activity within the basal ganglia. Peripheral factors do only play a minor role for the generation, maintenance, and modulation of PD tremor and other signs. The most likely candidates producing these neuronal oscillations are the weakly coupled neural networks of the basal ganglia-thalamo-cortical loops. However, the present evidence supports the view that the basal ganglia loops are influenced by other neuronal structures and systems and that the tuning of these loops by cerebello-thalamic mechanisms and by other modulator neurotransmitter systems entrain the abnormal synchronized oscillations. Neurosurgical procedures, such as lesions or high-frequency stimulation of different parts of the loop, might resume the normal unsynchronized activity of the basal ganglia circuitry, and, therefore, ameliorate the clinical symptoms of Parkinson's disease.


📜 SIMILAR VOLUMES


From functional neurosurgery to “interve
✍ Marwan I. Hariz 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 226 KB

## Abstract Articles on surgery for Parkinson's disease (PD), published between 1966 and 2001, were reviewed with respect to whether the first author had a neurosurgical affiliation, and whether the papers appeared in neurosurgical or non‐neurosurgical journals. Between 1966 and 1979, neurosurgeons

Neuroinflammation in the pathophysiology
✍ Anna L. Bartels; Klaus L. Leenders 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB

## Abstract Increasing evidence suggests that neuroinflammation is an active process in Parkinson's disease (PD) that contributes to ongoing neurodegeneration. PD brains and experimental PD models show elevated cytokine levels and up‐regulation of inflammatory‐associated factors as cyclo‐oxygenase‐

Switching from ergot to nonergot dopamin
✍ Katherine Grosset; Fiona Needleman; Graeme Macphee; Donald Grosset 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB

## Abstract Of 99 patients on ergot‐derived dopamine agonists informed about possible long‐term side effects, switching to a nonergot was undertaken in 88 (89%). There were adverse events in 26%. After 11 months, 82% were on their switch agonist and 93% were on any agonist. Switching dopamine agoni